A £37 million Bioscience Campus is to be set up at GlaxoSmithKline’s site at Stevenage, UK, with funding from the government, GlaxoSmithKline, and other partners.

A new campaign seeks to persuade regulators to set new rules for approving personalised treatments that are currently in clinical development.

Cancer research is not pursuing advances in knowledge likely to have the biggest impact on combating the disease in the next few decades, conference hears.

The €2 million Innovative Medicines initiative, set up to restore the competitive position of Europe’s pharma sector, has entered its second phase.